Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingkun Xu

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Functional & Integrative Genomics|March 28, 2023
Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarkerJiayi Li, Haiguang Hou, Jinhao Sun, et al.
Frontiers in Oncology|January 6, 2023
Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective studyLingfeng Tang, Zhenghang Li, Linshan Jiang, et al.
Journal of Oncology|July 26, 2021
Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular TargetGuangzhen Wu, Xiaowei Li, Yuanxin Liu, et al.
Functional & Integrative Genomics|May 20, 2024
Retraction Note: Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarkerJiayi Li, Haiguang Hou, Jinhao Sun, et al.
Cell Death & Disease|May 30, 2019
Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?Guangzhen Wu, Qinglian Wang, Yingkun Xu, et al.
Gene|November 12, 2022
NEK2 is associated with poor prognosis of clear cell renal cell carcinoma and promotes tumor cell growth and metastasisXiaoli Feng, Yang Jiang, Yue Cui, et al.
Computational and Mathematical Methods in Medicine|August 19, 2022
Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical CarcinomaXiunan Li, Jiayi Li, Leizuo Zhao, et al.
European Journal of Pharmacology|September 7, 2019
FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinomaGuangzhen Wu, Yingkun Xu, Qifei Wang, et al.
Journal of Oncology|January 18, 2021
Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway ExplorationGuangzhen Wu, Yingkun Xu, Chenglin Han, et al.
Frontiers in Cell and Developmental Biology|March 21, 2022
Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung MetastasisLi Liu, Chenxi Chen, Gang Tu, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Functional & Integrative Genomics|March 28, 2023
Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarkerJiayi Li, Haiguang Hou, Jinhao Sun, et al.
Frontiers in Oncology|January 6, 2023
Efficacy evaluation of neoadjuvant chemotherapy in patients with HER2-low expression breast cancer: A real-world retrospective studyLingfeng Tang, Zhenghang Li, Linshan Jiang, et al.
Journal of Oncology|July 26, 2021
Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular TargetGuangzhen Wu, Xiaowei Li, Yuanxin Liu, et al.
Functional & Integrative Genomics|May 20, 2024
Retraction Note: Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarkerJiayi Li, Haiguang Hou, Jinhao Sun, et al.
Cell Death & Disease|May 30, 2019
Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?Guangzhen Wu, Qinglian Wang, Yingkun Xu, et al.
Gene|November 12, 2022
NEK2 is associated with poor prognosis of clear cell renal cell carcinoma and promotes tumor cell growth and metastasisXiaoli Feng, Yang Jiang, Yue Cui, et al.
Computational and Mathematical Methods in Medicine|August 19, 2022
Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical CarcinomaXiunan Li, Jiayi Li, Leizuo Zhao, et al.
European Journal of Pharmacology|September 7, 2019
FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinomaGuangzhen Wu, Yingkun Xu, Qifei Wang, et al.
Journal of Oncology|January 18, 2021
Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway ExplorationGuangzhen Wu, Yingkun Xu, Chenglin Han, et al.
Frontiers in Cell and Developmental Biology|March 21, 2022
Pyroptosis-Related lncRNAs for Predicting the Prognosis and Identifying Immune Microenvironment Infiltration in Breast Cancer Lung MetastasisLi Liu, Chenxi Chen, Gang Tu, et al.
Pageof 7